Abstract
Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study - European Journal of Breast Health

This publication has 18 references indexed in Scilit: